BTIG Downgrades DexCom (DXCM) to Neutral
- Dow opens at record high led by oil, bank stocks
- Oil tops $55 for first time in 16 months as OPEC deal fuels buying
- Consolidated Communications (CNSL) to Acquire FairPoint Communications (FRP) in $1.5B Deal
- Wall St. stock futures fall after Italy referendum
- Pre-Open Stock Movers 12/05: (FRP) (GMED) (CHK) Higher; (CERC) (HDSN) (MRVL) Lower (more...)
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
BTIG downgraded DexCom (NASDAQ: DXCM) from Buy to Neutral and removed its price target. Analyst Sean Lavin thinks shares are fairly valued given the stock's run.
"While we do not think shares are overvalued and could argue for a bit more upside as revenue should continue to exceed guidance in our opinion, we do feel a lot of good news is priced in, and given the historical volatility we would like more significant upside than we see at this time to maintain our Buy rating. One additional issue is investors are starting to focus on margins and profitability," said Lavin.
Shares of DexCom closed at $91.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Goldman Sachs Downgrades Marvell (MRVL) to Sell
- Casey's General Stores (CASY) Recommended Long at Off Wall Street
- KLR Group Downgrades PDC Energy (PDCE) to Accumulate
Create E-mail Alert Related CategoriesAnalyst Comments, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!